Reduced sensitivity of saquinavir: An update on genotyping from phase I/II trials

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 95-97

  Jacobsen, H ^a   Haenggi, M ^a   Ott, M ^a   Duncan, I B ^a   Andreoni, M ^a   Vella, S ^a   Mous, J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

HIV 1 proteinase; Inhibitors; Saquinavir

Indexed keywords

DNA; PROTEINASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; VIRUS ENZYME; VIRUS RNA; ZIDOVUDINE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; PERIPHERAL LYMPHOCYTE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS MUTATION;

EID: 0029926056     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00927-2     Document Type: Conference Paper

References (0)